Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 USD | -25.00% |
|
-.--% | -.--% |
2023 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
Performance
1 day | -25.00% | ||
1 year | -30.77% | ||
3 years | -67.63% | ||
5 years | -76.92% |
Volumes
marketsBasic data
Highs and lows
![Extreme 0.45](/images/extremecours_fleche.png)
![Extreme 0.45](/images/extremecours_fleche.png)
![Extreme 0.45](/images/extremecours_fleche.png)
![Extreme 0.1](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-25.00% | -.--% | -.--% | -30.77% | 2.99M | ||
-3.58% | -7.27% | +40.80% | +7.73% | 53.67B | ||
-0.17% | -3.98% | +35.79% | -14.93% | 38.86B | ||
-0.57% | -2.96% | -8.05% | -1.86% | 38.76B | ||
+0.44% | -4.03% | -8.98% | +11.76% | 27.27B | ||
-1.44% | -1.86% | +10.69% | +34.12% | 25.91B | ||
+0.21% | +4.98% | -16.21% | -20.73% | 20.29B | ||
+0.16% | +4.75% | +31.00% | +25.47% | 12.78B | ||
-0.05% | -1.81% | +28.51% | +78.55% | 12.18B | ||
-1.31% | -2.27% | -1.67% | -0.97% | 11.96B | ||
-1.40% | -2.48% | -11.39% | +0.24% | 10.79B | ||
-2.33% | -5.60% | -5.43% | -11.83% | 9.39B | ||
-0.31% | +1.02% | +21.92% | -7.47% | 6.67B | ||
+8.78% | 0.00% | - | - | 6.65B | ||
-0.79% | +2.14% | +14.43% | +73.35% | 6.61B | ||
-2.82% | -4.26% | +34.66% | +53.62% | 6.37B | ||
Average | -1.89% | -1.43% | +11.07% | +13.09% | ||
Weighted average by Cap. | -0.90% | -2.67% | +14.15% | +8.83% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2023 | -35.71% | ||
2022 | -.--% | ||
2021 | -36.36% | ||
2020 | -26.67% | ||
2019 | +500.00% | ||
2018 | -75.00% | ||
2017 | -71.43% | ||
2016 | +40.00% | ||
2015 | -.--% |
- Stock Market
- Equities
- FNAM Stock
- Quotes Evolutionary Genomics, Inc.